EP2799428
Glúkagonmótverki
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.8.2009EP published:
16.11.2016EP application number:
14179199.6
EP translation filed:
10.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
12.8.2029Expiry date:
12.8.2020
Title:
Glucagon antagonists
Timeline
Today
13.8.2009EP application
16.11.2016EP Publication
10.2.2017Translation submitted
15.3.2017Registration published
12.8.2020Expires
Owner
Name:
Metabasis Therapeutics, Inc.Address:
3911 Sorrento Valley Boulevard, Suite 110, 92121, San Diego, CA, US
Inventor
Name:
Gomez-Galeno, Jorge, E.Address:
San Diego, CA, US
Name:
Hecker, Scott, J.Address:
Del Mar, CA, US
Name:
Dang, QunAddress:
San Diego, CA, US
Name:
Reddy, Mali VenkatAddress:
La Jolla, CA, US
Name:
Sun, ZhiliAddress:
San Diego, CA, US
Name:
Grote, Matthew, P.Address:
La Jolla, CA, US
Name:
Nguyen, Thanh HuuAddress:
Solana Beach, CA, US
Name:
Lemus, Robert, HuertaAddress:
Escondido, CA, US
Name:
Li, HaiqingAddress:
La Jolla, CA, US
Agent
Name:
Guðjón Styrkársson, hrl.Address:
Njálsgötu 110, 105, Reykjavík,
Priority
Number:
88697 PDate:
13.8.2008Country:
US
Classification
Categories:
C07C 309/15, A61K 31/185, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 5.10.2017
Expires: 12.8.2018
Payer: Árnason Faktor
Number: 10
Paid: 17.7.2018
Expires: 12.8.2019
Payer: Örn Þór, slf.
Number: 11
Paid: 15.7.2019
Expires: 12.8.2020
Payer: Örn Þór, slf.